nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.06.2008 | Review

Novel immune regulatory pathways and their role in immune reconstitution syndrome in organ transplant recipients with invasive mycoses

verfasst von: N. Singh

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Abstract

Immune regulatory pathways involving the newly discovered T regulatory (Treg) and Th17 cells are amongst the principal targets of immunosuppressive agents employed in transplant recipients and key mediators of host inflammatory responses in fungal infections. These novel signaling pathways, in concert with or independent of Th1/Th2 responses, have potentially important implications for yielding valuable insights into the pathogenesis of immune reconstitution syndrome (IRS) in transplant recipients, for aiding the diagnosis of this entity, and for achieving a balance of immune responses that enhance host immunity while curbing unfettered inflammation in IRS.

Singh N, Perfect JR (2007) Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis 7:395–401PubMedCrossRef

Lortholary O, Fontanet A, Memain N et al (2005) Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 19:1043–1049PubMedCrossRef

Shelburne SA, Hamill RJ, Rodriguez-Barradas MC et al (2002) Immune reconstitution inflammatory syndrome, emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 81:213–227PubMedCrossRef

Casadevall A, Pirofski LA (2003) The damage-response framework of microbial pathogenesis. Nat Rev Microbiol 1:17–24PubMedCrossRef

Shelburne SA, Darcourt J, White C Jr et al (2005) The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 40:1045–1052CrossRef

Hirsch HH, Kaufmann G, Sendi P et al (2004) Immune reconstitution in HIV-infected patients. Clin Infect Dis 38:1159–1166PubMedCrossRef

Cheng VCC, Yuen KY, Wong SSY et al (2001) Immunorestitution disease in patients not infected with HIV. Eur J Clin Microbiol Infect Dis 20:402–406PubMedCrossRef

Einsiedel L, Gordon DL, Dyer JR (2004) Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV seronegative woman. Clin Infect Dis 39:e78–e82PubMedCrossRef

Clemons KV, Stevens DA (2001) Overview of host defense mechanisms in systemic mycoses and the basis for immunotherapy. Semin Respir Infect 16:60–66PubMedCrossRef

10.

Romani L, Pucetti P (2007) Controlling pathogenic inflammation to fungi. Expert Rev Anti Infect Ther 5:1007–1017PubMedCrossRef

11.

Cenci E, Perito S, Enssle KH et al (1997) Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 65:564–570PubMed

12.

Parkin J, Cohen B (2001) An overview of the immune system. Lancet 357:1777–1789PubMedCrossRef

13.

Goriely S, Goldman M (2007) The interleukin-12 family: new players in transplantation immunity? Am J Transplant 7:278–284PubMedCrossRef

14.

Nelms K, Keegan A, Zamorano J et al (1999) The IL-4 receptor: signaling mechanisms and biologic functions. Ann Rev Immunol 17:701–738CrossRef

15.

Afzali B, Lombardi G, Lechler R, Lord G (2007) The role of T helper (TH17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148:32–46PubMedCrossRef

16.

Mangan P, Harrington L, O’Quinn D et al (2006) Transforming growth factor-beta induces development of the T (H) 17 lineage. Nature 441:231–234PubMedCrossRef

17.

Cooke A (2006) Th17 cells in inflammatory conditions. Rev Diabetic Stud 372–375

18.

Bi Y, Guangwei L, Yang R (2007) Th17 cell induction and immune regulatory effects. J Cell Physiol 211:273–278PubMedCrossRef

19.

Schmidt-Weber C, Akdis M, Akdis C (2007) TH17 cells in the big picture of immunology. J Allergy Clin Immunol 120:247–254PubMedCrossRef

20.

Stockinger B, Veldhoen M (2007) Differentiation and function of Th17 T cells. Curr Opin Immunol 3:281–286CrossRef

21.

Bettelli E, Carrier Y, Gao W et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235–238PubMedCrossRef

22.

Veldhoen M, Hocking R, Atkins C et al (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de nova differentiation of IL-17-producing T cells. Immunity 24:179–189PubMedCrossRef

23.

Pyzik M, Piccirillo C (2007) TGF-beta 1 modulates FoxP3 expression and regulatory activity in distinct CD4+ T cell subsets. J Leukov Biol 82:335–346CrossRef

24.

Chen W, Jin W, Hardegen N et al (2003) Conversion of peripheral TGF-beta CD4+CD5-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 1875–1886

25.

Yagi H, Normura T, Nakamura K et al (2004) Crucial role of FoxP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 11:1643–1656CrossRef

26.

Sakaguchi S (2005) Naturally arising FoxP3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nature Immun 6:345–354PubMedCrossRef

27.

Fontenot J, Gavin M, Rudensky A (2003) FoxP3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immun 4:330–336PubMedCrossRef

28.

Waldmann H, Graca L, Cobbold S et al (2004) Regulatory T cells and organ transplantation. Semin Immunol 16:119–126PubMedCrossRef

29.

de Kleer I, Wedderburn L, Taams L et al (2004) CD4+CD25bright regulatory T cells activity regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 10:6423–6435

30.

Matthys P, Vermeire K, Mitera T et al (1998) Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice. Eur J Immunol 28:2143–2151PubMedCrossRef

31.

Tang Q, Henriksen K, Bi M et al (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199:1455–1465PubMedCrossRef

32.

Long E, Wood K (2007) Understanding FOXP3: progress towards achieving transplantation tolerance. Transplantation 84:459–461PubMedCrossRef

33.

Gras J, Cornet A, Latinne D et al (2004) Evidence that Th1/Th2 immune deviation impacts on early graft acceptance after pediatric liver transplantation: results of immunological monitoring in 40 children. Am J Transplant 4:444CrossRef

34.

Saggi B, Fisher R, Naar J et al (1999) Intragraft cytokine expression in tolerant rat renal allografts with rapamycin and cyclosporin immunosuppression. Clin Transplant 13:90–97PubMedCrossRef

35.

Salama A, Najafian N, Clarkson M et al (2003) Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 6:1643–1651CrossRef

36.

Graca L, Cobbold S, Waldmann H (2002) Identification of regulatory T cells in tolerated allografts. J Exp Med 195:1641PubMedCrossRef

37.

Bloom DD, Brahmbhatt R, Knechtle S (2007) Flow cytometric characterization regulatory T lymphocyte populations in renal transplant patients treated with Campath and tacrolimus. Presented at the American Transplant Congress, May 5–7, San Francisco, CA

38.

Lopez M, Clarkson M, Sayegh A et al (2006) A novel mechanism of action for anti-thymocyte globulin induction of CD4+CD25+FoxP3+ regulatory T cells. J Am Soc Nephrol 10:2644–2646

39.

Watanabe T, Masuyama J, Sohma Y et al (2006) CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells. Clin Immunol 3:247–259CrossRef

40.

Karagiannidis C, Akdis M, Holopainen P et al (2004) Glucocorticoids up-regulate CAP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114:1425–1433PubMedCrossRef

41.

Segundo D, Ruiz J, Izquierdo M et al (2006) Calcineurin inhibitors, but no rapamycin, reduce percentages of CD4+CD25+FoxP3+ Regulatory T cells in renal transplant recipients. Transplantation 82:550–557PubMedCrossRef

42.

Baan C, van der Mast B, Klepper M et al (2005) Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin of the induction of FoxP3 in human T Cells. Transplantation 80:110–117PubMedCrossRef

43.

Bensinger S, Walsh P, Zhang J (2004) Distinct IL-2 receptor signaling pattern in CD4+CD25+regulatory T cells. J Immunol 172:5287PubMed

44.

Fontenot J, Rasmussen J, Gavin M et al (2005) A function for interleukin 2 in FoxP3-expressing regulatory T cells. Nat Immunol 6:1142PubMedCrossRef

45.

Battaglia M, Stabilini A, Roncarolo M (2005) Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105:4743–4748PubMedCrossRef

46.

Nagai H, Guo J, Choi H et al (1995) Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. J Infect Dis 172:1554–1560PubMed

47.

Kawakami K (2004) Regulation by innate immune T lymphocytes in the host defense against pulmonary infection with Cryptococcus neoformans. Jpn J Infect Dis 57:137–145PubMed

48.

Decken K, Kohler G, Palmer-Lehmann K et al (1998) Interleukin-12 is essential for protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun 66:4994–5000PubMed

49.

Aguirre K, Havell EA, Gibson GW (1995) Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 63:1725–1731PubMed

50.

Vecchiarelli A, Retini C, Monari C et al (1996) Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun 64:2846–2849PubMed

51.

Vecchiarelli A, Retini C, Pietrella D et al (1995) Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1β secretion from human monocytes. Infect Immun 63:2919–2923PubMed

52.

Rudner X, Happel K, Young E et al (2007) Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 75:3055–3061PubMedCrossRef

53.

Zelante T, De Luca A, Bonifazi P et al (2007) IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37:2695–2706PubMedCrossRef

54.

Rogers PD, Pearson MM, Cleary JD et al (2002) Differential expression of genes encoding immunomodulatory proteins in response to amphotericin B in human mononuclear cells identified by cDNA microarray analysis. J Antimicrob Chemotherap 50:811–817CrossRef

55.

Razonable RR, Henault M, Lee LN et al (2005) Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2. Antimicrob Ag Chemother 4:1617–1621CrossRef

56.

Shadkchan Y, Keisari Y, Segal E (2004) Cytokines in mice treated with amphotericin B-intralipid. Med Mycol 42:123–128PubMedCrossRef

57.

Hohl T, Feldmesser M, Perlin D et al (2007) Caspofungin modulates inflammatory responses to Aspergillus fumgiatus through stage-specific effects on fungal β-glucan exposure. Annual meeting of the Infectious Diseases Society of America, 4–7 October, San Diego, CA

58.

Wheeler RT, Fink GR (2006) A drug-sensitive genetic network masks fungi from the immune system. PLOS Pathogens 2:328–339CrossRef

59.

Lortholary O, Sitbon K, Dromer F et al (2005) Evidence for HIV and Cryptococcus neoformans interactions on the pro- and antiinflammatory responses in blood during AIDS-associated cryptococcosis. Clin Microbiol Infect 11:296–300PubMedCrossRef

60.

Singh N, Lortholary O, Alexander BD et al (2005) An “immune reconstitution syndrome”-like entity associated with Cryptococcus neoformans infections in organ transplant recipients. Clin Infect Dis 40:1756–1761PubMedCrossRef

61.

Breton G, Adle-Biassette H, Therby A et al (2006) Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 20:119–121PubMedCrossRef

62.

Cheng VCC, Yuen KY, Chan WM et al (2000) Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 30:882–892PubMedCrossRef

63.

Miceli M, Maertens J, Buve K et al (2007) Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: proof of principle, description, and clinical and research implications. Cancer 110:112–120PubMedCrossRef

64.

Tang Q, Bluestone J (2006) Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 212:217–237PubMedCrossRef

65.

Tarbell K, Petit L, Zuo X et al (2007) Dendritic cell-expanded, islet-specific CD4+CD25+CD62L+regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 204:191–201PubMedCrossRef

66.

Tarbell K, Yamazaki S, Olson K et al (2004) CD25+CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 199:1467–1477PubMedCrossRef

67.

Ingram P, Howman R, Leahy M et al (2007) Cryptococcal immune reconstitution inflammatory syndrome following alemtuzumab therapy. Clin Infect Dis 12:115–117CrossRef

Titel: Novel immune regulatory pathways and their role in immune reconstitution syndrome in organ transplant recipients with invasive mycoses
verfasst von: N. Singh
Publikationsdatum: 01.06.2008
Verlag: Springer-Verlag
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 6/2008
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-008-0461-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2008

Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis

Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts

Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin

Prevalence of mycobacteremia in Indian HIV-infected patients detected by the MB/BacT automated culture system

Mannitol and inflammatory markers in the cerebral spinal fluid of HIV-infected patients with cryptococcal meningitis